SynthesisJournal of human nutrition and dietetics : the official journal of the British Dietetic Association2026
Effects of Walnut (Juglans regia L.) on Blood Pressure and Endothelial Function in Adults: A Systematic Review and Dose-Response Meta-Analysis.
Synthesis in Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWalnuts (Juglans regia L.) are rich in bioactive compounds with anti-inflammatory and antioxidant properties, which may benefit cardiovascular health. However, the evidence regarding their effects on blood pressure (BP) and endothelial function remains inconclusive.
objectiveThis systematic review and meta-analysis aimed to evaluate the effects of walnut consumption on systolic and diastolic BP (SBP and DBP), and endothelial function markers, including flow-mediated dilation (FMD), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in adults.
methodsA systematic search of PubMed, Web of Science and Scopus was conducted through February 2026 to identify relevant randomized controlled trials (RCTs). Weighted mean differences (WMDs) with corresponding 95% confidence intervals (CIs) were estimated using a random-effects model. Subgroup analyses were conducted based on intervention duration and walnut dosage. Dose-response associations were further examined using both linear and nonlinear modelling approaches.
resultsPooled analysis data from 36 RCTs showed no significant overall effect of walnut consumption on SBP (WMD: -0.65 mmHg; 95% CI: -1.61 to 0.30, p = 0.183) or DBP (WMD: -0.68 mmHg; 95% CI: -1.56 to 0.19, p = 0.125). However, significant reductions in DBP were observed in studies lasting ≥ 12 weeks. Walnut intake significantly increased FMD (WMD: 0.93%; 95% CI: 0.27 to 1.59, p = 0.006), but had no overall significant effect on ICAM-1 (WMD = -0.56 ng/mL; 95% CI: -2.50 to 1.38; p = 0.571) and VCAM-1 (WMD: -8.68 ng/mL, p = 0.663). Subgroup analysis indicated a reduction in ICAM-1 in participants at high cardiovascular risk. The dose-response analysis supported a greater effect on ICAM-1 at higher walnut intakes.
conclusionWalnut supplementation may improve vascular health by reducing endothelial dysfunction and promoting a dose-dependent reduction in endothelial inflammation.
trial registrationInternational Prospective Register of Systematic Reviews (PROSPERO): CRD420261461684.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.